GM23785
Fibroblast from Skin, Unspecified
Description:
LESCH-NYHAN SYNDROME; LNS
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE 1; HPRT1; HPRT
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases |
Biopsy Source
|
Unspecified
|
Cell Type
|
Fibroblast
|
Tissue Type
|
Skin
|
Transformant
|
Untransformed
|
Sample Source
|
Fibroblast from Skin, Unspecified
|
Race
|
White
|
Ethnicity
|
Not Hispanic/Latino
|
Family Member
|
2
|
Family History
|
Y
|
Relation to Proband
|
brother
|
Confirmation
|
Molecular characterization before cell line submission to CCR
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
PDL at Freeze |
1.97 |
Passage Frozen |
2 |
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by LINE assay |
|
Gene |
HPRT1 |
Chromosomal Location |
Xq26-q27.2 |
Allelic Variant 1 |
308000.0031; LESCH-NYHAN SYNDROME |
Identified Mutation |
IVS7DS, G-A, +5; In cell line RJK1934 from a patient with LNS, Gibbs et al. (1990) found a GTAAGT-to-GTAAAT change at the beginning of intron 7. Interference with processing resulted from mutation in the donor splice site. See 308000.0029 for the corresponding mutation in intron 8.
|
Remarks |
Clinically affected; symptom onset before 1 year of age; delivered by Caesarean section because of fetal distress; onset of self-injury at age 3 years; motor delay at age 6 months; spasticity of legs and arms; rigidity in arms; limb posturing at 18 months of age; dystonia; hyper-reflexia of legs; clonus of ankles; gastrostomy tube; HPRT mutation: hemizygous for a G>A transition in intron 7 of the HPRT1 gene (IVS7+5G>A); HPRT enzyme: <1%; treatments include physical, occupational therapy, psychological therapy, and speech therapy; medications include diazepam, omeprazole, cetirizine, and fluticazone; orthotics; affected brother is GM23784 |
Jinnah HA, Visser JE, Harris JC, Verdu A, Larovere L, Ceballos-Picot I, Gonzalez-Alegre P, Neychev V, Torres RJ, Dulac O, Desguerre I, Schretlen DJ, Robey KL, Barabas G, Bloem BR, Nyhan W, De Kremer R, Eddey GE, Puig JG, Reich SG, Lesch-Nyhan Disease International Study Group SG, Delineation of the motor disorder of Lesch-Nyhan disease Brain : a journal of neurology129:1201-17 2006 |
PubMed ID: 16549399 |
Cumulative PDL at Freeze |
3.6 |
Passage Frozen |
2 |
Split Ratio |
1:4 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
3% |
Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not inactivated |
Supplement |
- |
|
|